Icosagen (company)

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This article needs to be updated. Please help update this article to reflect recent events or newly available information. (February 2024) This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (June 2024) (Learn how and when to remove this message) (Learn how and when to remove this message)

Icosagen AS is one of the leading biotechnology companies in Estonia^[1] providing medical diagnostics services and performing custom research programs for the biopharmaceutical industry. Formed in 1999 as Quattromed AS, the company has been called Icosagen since 2009.^[2]

Quattromed was established in 1999 as a spin-off from Tartu University.^[3] It is based in Tartu, Estonia. Employing 80 full-time employees, it has grown into the largest biotechnology company in Estonia. Quattromed started with offering molecular diagnostic services, the activities today cover molecular and clinical diagnostics (Quattromed HTI Laboratories), life science products (Quattromed), latex allergen testing (Quattromed Ltd) and protein production (Quattromed Cell Factory).

Quattromed’s activities are divided into three branches: medical diagnostics division, technology development division and life science products division. Its main focus of activities is in gene expression and protein production. In-house proprietary technologies are used combined with extensive process know-how and partnership with academic and industrial groups. Quattromed has three patent applications in its IP portfolio, about ten technology licenses and one trade mark.

• Biologics
• Biopharmaceutical
• Cell culture
• FITkit
• Genetic engineering
• Molecular biology

• Official website